| Literature DB >> 34273256 |
YanHong Li1, Mingchuan Gan1, Tao Tang1, Jiahao Shao1, Tianfu Lai1, Yuan Ma1, Mauricio A Elzo2, Xianbo Jia1, Shenqiang Hu1, Jie Wang1, SongJia Lai1.
Abstract
Fatty acids of intramuscular fat (IMF) in rabbits can influence meat quality, but it is unclear which fatty acids benefit to human health. A rabbit model of weight gain and weight loss was constructed using two rabbit groups and two growth stages. Stage 1 included control group1 fed a commercial diet(CG1) and experimental group1 fed a high fat diet (EG1). Stage 2 include control group2(CG2) and experimental group2 (EG2) both fed a restricted commercial diet. We detected differences in blood biochemical indicators as well as changes in intramuscular adipose cells and intramuscular fatty acid content in control and experiment groups at two stages. High fat induction can make rabbits become obese, have higher concentrations of glucose (GLU), total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C) and free fatty acid (FFA), and lower concentrations of insulin (INS). In addition, a high-fat diet promotes hypertrophy of precursor adipocytes in femoral muscles. Conversely, a restricted diet causes weight loss, decreases the concentration of TG, FFA, and INS in CG2 and EG2, and increases the deposition of unsaturated fatty acids in the femoral muscle. The content of monounsaturated trans oleic acid (C18:1n-9T) in EG2 was significantly higher than in CG2, whereas oleic acid (C18:1n-9C) was significantly lower in EG2 than in CG2. The polyunsaturated fatty acids Linolenate (C18:3 n-3) and cis-5,8,11,14,17-Eicosapentaenoate (C20:5 n-3) increased in CG2 and EG2. The content of Linoleate (C18:2 n-6) and γ-Linolenic acid (C18:3 n-6) significantly increased in CG2. The content of cis-11,14-Eicosatrienoic acid (C20:2) decreased significantly in CG2, but increased significantly in EG2.Thus, a high-fat diet can increase the formation of unhealthy fatty acids. Conversely, weight loss due to a restricted diet leads to an increase in unsaturated fatty acids in the femoral muscle, indicating that it reduces obesity symptoms and it may improve meat quality in rabbit.Entities:
Keywords: fatty acids; femoral muscle; morphology; rabbit; weight loss
Mesh:
Substances:
Year: 2021 PMID: 34273256 PMCID: PMC8464271 DOI: 10.1002/vms3.576
Source DB: PubMed Journal: Vet Med Sci ISSN: 2053-1095
Nutritional composition of the commercial and mixed diets
| Diet | CP | CF | CA | CF | Calcium/Phosphorus | DE | Pork lard |
|---|---|---|---|---|---|---|---|
| Commercial diet | ≥16.0 | ≥2.0 | 10 | 10.0–16.0 | 2:1 | 10.47 ≥ MJ/kg | 0 |
| Mixed diet | ≥16.0 | ≥2.0 | 10 | 10.0‐16.0 | 2:1 | 10.47 ≥ MJ/kg | 10% |
Note: The feed terms of Crude protein, Crude fat, Crude ash, Crude fiber, Digestive energy use the capital letters CP, CF, CA, CF and DE.
FIGURE 1Experimental design. Stage1 = high fat induction stage; Stage2 = diet restriction stage
Average daily feed intake of each rabbits in the two stages of the experiment (g/d)
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
| Age, d | 35 | 36 | 37 | 38 | 39 | 40 | 41 | Mean |
| CG(n=16) | 69.06 | 44.38 | 71.56 | 73.44 | 72.19 | 75.00 | 62.50 | 66.88 |
| EG(n=16) | 73.75 | 50.00 | 78.13 | 77.19 | 77.50 | 70.63 | 62.50 | 69.96 |
| Age, d | 42 | 43 | 44 | 45 | 46 | 47 | 48 | Mean |
| CG(n=16) | 109.69 | 100.00 | 78.13 | 100.00 | 100.00 | 71.88 | 100.00 | 94.24 |
| EG(n=16) | 105.63 | 96.25 | 74.06 | 97.19 | 93.44 | 61.56 | 100.00 | 89.73 |
| Age, d | 49 | 50 | 51 | 52 | 53 | 54 | 55 | Mean |
| CG(n=16) | 100.00 | 99.69 | 97.81 | 97.50 | 99.69 | 85.31 | 95.94 | 96.56 |
| EG(n=16) | 93.44 | 100.00 | 98.75 | 97.19 | 98.44 | 80.31 | 95.63 | 94.82 |
| Age, d | 56 | 57 | 58 | 59 | 60 | 61 | 62 | Mean |
| CG(n=16) | 101.56 | 84.06 | 97.81 | 100.31 | 95.63 | 107.50 | 102.81 | 98.53 |
| EG(n=16) | 123.33 | 65.42 | 98.33 | 128.75 | 133.75 | 138.75 | 121.25 | 115.65 |
| Age, d | 63 | 64 | 65 | 66 | 67 | 68 | 69 | Mean |
| CG(n=12) | 94.69 | 118.44 | 105.00 | 101.56 | 114.38 | 103.75 | 103.75 | 105.94 |
| EG(n=12) | 89.58 | 96.67 | 81.25 | 94.54 | 82.50 | 55.42 | 55.38 | 79.33 |
Stage 1. Four rabbits in each group were eliminated due to digestive tract diseases and weak body. Three rabbits were placed together for breeding and two rabbits were selected for feeding after 56 days of age in the CG and EG groups.
Stage 2. Rabbits were raised in pairs. All rabbits had good body condition.
FIGURE 2Rabbit weights at the beginning of the trial (35 days of age), at the end of the high fat induction stage (70 days of age), and at the end of the diet restriction stage (90 days of age) in the control group (CG) and the experimental group (EG); **p < 0.01; *p < 0.05
Blood biochemical indicators in the control and experimental rabbit groups at the end of the high‐fat induction and the diet restriction feeding stages
| Stage1 | Stage2 | |||||
|---|---|---|---|---|---|---|
| Biochemical indicator2 | CG‐1 | EG‐1 | CG‐2 | EG‐2 | SEM | |
| GLU (mmol/L) | 7.34 | 8.53b | 7.22 | 8.67B | 0.15 | <0.01 |
| TC (mmol/L) | 1.30 | 2.17b | 3.57a | 4.21A | 0.25 | <0.01 |
| TG (mmol/L) | 0.82A | 1.44ab | 0.42 | 0.61 | 0.10 | <0.01 |
| LDL‐C (mmol/L) | 0.49 | 0.67b | 2.51A | 3.49Ab | 0.21 | <0.01 |
| FFA (μmol/L) | 111.22 | 637.92AB | 112.49 | 212.43B | 3.35 | <0.01 |
| INS (mU/L) | 28.59AB | 2.64A | 0.94 | 0.99 | 0.16 | <0.01 |
CG‐1, Control group, high‐fat induction stage; EG‐1, Experimental group, high fat induction stage; CG‐2, Control group, diet restriction stage; EG‐2, Experimental group, diet restriction stage. Significance of differences between the two feeding stages within the control and experimental groups (A = p < 0.01; a = p < 0.05). Significance of differences between the control and experimental groups within feeding stages (B = p < 0.01; b = p < 0.05).
2GLU, TC, TG, LDL‐C, FFA and INS represent glucose, cholesterol, triglyceride, low density lipoprotein—cholesterol, free fatty acid, insulin.
FIGURE 3Morphology of adipocytes in the femoral muscle (vastus intermedius) of rabbits from the control group, high fat induction stage (CG‐1), the experimental group, high fat induction stage (EG‐1), the control group, diet restriction stage (CG‐2), and the experimental group, diet restriction stage (EG‐2). Both a and b in the figure represent muscle nucleus and adipocyte, respectively
Morphological characteristics of muscle adipocytes in the control and experimental rabbit groups at the end of the high‐fat induction and the diet restriction feeding stages
| Stage1 | Stage2 | |||||
|---|---|---|---|---|---|---|
| Group | CG1 | EG1 | CG2 | EG2 | SEM | |
| Area (μm | 483.96A | 506.54 | 374.79 | 625.90aB | 14.78 | <0.01 |
| Diameter (μm) | 22.68a | 24.83ab | 21.52 | 23.19b | 0.37 | <0.01 |
| Number | 26.67B | 20.67 | 40.67Ab | 24.00 | 1.35 | <0.01 |
| Density (per/mm2) | 299.93B | 232.45A | 458.90AB | 135.41 | 11.73 | <0.01 |
Measurement area = 88 908.17 μm.2
CG‐1, control group, high‐fat induction stage; EG‐1, experimental group, high‐fat induction stage; CG‐2, control group, diet restriction stage; EG‐2, experimental group, diet restriction stage. Significance of differences between the two feeding stages within the control and experimental groups (A = p < 0.01; a = p < 0.05). Significance of differences between the control and experimental groups within feeding stages (B = p < 0.01; b =p < 0.05).
Fatty acid profiles in the control and experimental rabbit groups at the end of the high‐fat induction and the diet restriction feeding stages
| Stage 1 | Stage 2 | |||||
|---|---|---|---|---|---|---|
| Fatty acid | CG1 (n=4) | EG1 (n=4) | CG2 (n=4) | EG2 (n=4) | SEM | |
| C14:0 | 9.80AB | 5.09 | 5.54b | 4.79 | 0.18 | <0.01 |
| C15:0 | 18.08AB | 6.51 | 11.84b | 8.00a | 0.40 | <0.01 |
| C16:0 | 106.76 | 106.56 | 154.77Ab | 117.08 | 1.88 | <0.01 |
| C18:0 | 41.26aB | 35.60 | 31.05 | 28.64 | 0.67 | <0.01 |
| C20:0 | 218.53b | 193.96A | 214.53B | 167.25 | 1.44 | <0.01 |
| C21:0 | 244.65 | 291.26B | 289.17A | 356.7AB | 2.43 | <0.01 |
| ΣSFA | 639.11 | 639.01 | 706.92AB | 682.49A | 4.26 | <0.01 |
| C14:1 | 0.14AB | 0.06 | 0.07 | 0.07 | 0.00 | <0.01 |
| C15:1 | 0.23 | 0.22 | 0.28 | 0.34 | 0.02 | <0.01 |
| C16:1 | 0.42B | 0.13 | 0.21b | 0.16 | 0.01 | <0.01 |
| C17:1 | 0.16B | 0.03 | 0.15B | 0.02 | 0.01 | <0.01 |
| C18:1n‐9T | 13.39A | 17.66B | 1.20 | 12.86B | 0.16 | <0.01 |
| C18:1n‐9C | 11.08 | 11.16 | 18.05AB | 12.07 | 0.41 | <0.01 |
| C20:1 | 0.19 | 0.21 | 0.25 | 0.19 | 0.01 | <0.01 |
| ΣMUFA | 25.65A | 29.51B | 20.23 | 25.74b | 0.46 | <0.01 |
| C18:3 n‐3 | 5.05 | 5.93b | 9.53A | 7.84a | 0.36 | <0.01 |
| C20:3 n‐3 | 0.06 | 0.06 | 0.08 | 0.05 | 0.01 | <0.05 |
| C20:5 n‐3 | 8.24 | 9.59 | 15.92A | 13.72a | 0.21 | <0.01 |
| C22:6 n‐3 | 1.34 | 1.46 | 2.74Ab | 2.24A | 0.10 | <0.01 |
| Σn‐3 | 14.71 | 17.06B | 28.29A | 23.87a | 0.59 | <0.01 |
| C18:2 n‐6 | 3.09 | 3.81 | 6.05A | 5.02 | 0.26 | <0.01 |
| C18:3 n‐6 | 10.57 | 9.82 | 14.26ab | 10.45 | 0.44 | <0.01 |
| C20:3 n‐6 | 0.12 | 0.10 | 0.13 | 0.12 | 0.01 | ns |
| C20:4 n‐6 | 0.50 | 0.81 | 1.00 | 0.55 | 0.25 | ns |
| Σn‐6 | 14.28 | 14.56 | 21.44aB | 16.17 | 0.70 | <0.01 |
| C20:2 | 7.57AB | 5.91 | 6.09 | 6.36a | 0.13 | <0.01 |
| C22:1 n‐9 | 0.01 | 0.03 | 0.05 | 0.05 | 0.00 | <0.01 |
| C22:2 | 0.05 | 0.03 | 0.02 | 0.05 | 0.00 | <0.01 |
| ΣPUFA | 7.65aB | 5.98 | 6.17 | 6.45 | 0.13 | <0.01 |
Unit of measurement, mg/100 g of total fat; Sample size = 0.2 g; CG‐1, Control group, high‐fat induction stage; EG‐1, experimental group, high‐fat induction stage; CG‐2, control group, diet restriction stage; EG‐2, experimental group, diet restriction stage. Significance of differences between the two feeding stages within the control and experimental groups (A = p < 0.01; a = p < 0.05).
Significance of differences between the control and experimental groups within feeding stages (B = p < 0.01; b =p < 0.05).
2 SFA = saturated fatty acids; MUFA = monounsaturatedfatty acids; PUFA = polyunsaturated fatty acids.